Skip to main content
. 2018 Apr 25;15(5):851. doi: 10.3390/ijerph15050851

Table 2.

Sample characteristics by intervention condition.

Total (n = 181) CDSMP (n = 109) wCDSMP (n = 72) Χ2 or t p
Age (range 23 to 72) 47.90 (±10.10) 46.51 (±9.78) 49.99 (±10.29) 2.27 0.024
Sex 0.01 0.937
Male 23 (12.9%) 14 (13.1%) 9 (12.7%)
Female 155 (87.1%) 93 (86.9%) 62 (87.3%)
Race 1.59 0.208
Non-Hispanic White 107 (62.2%) 68 (66.0%) 39 (56.5%)
Racial/Ethnic Minority 65 (37.8%) 35 (34.0%) 30 (43.5%)
Education 9.61 0.142
Some high school 2 (1.1%) 0 (0.0%) 2 (2.9%)
High school graduate or GED 14 (8.0%) 5 (4.8%) 9 (12.9%)
Some college or technical/vocational training 46 (26.3%) 26 (24.8%) 20 (28.6%)
Associate’s degree 25 (14.3%) 14 (13.3%) 11 (15.7%)
Bachelor’s degree 22 (12.6%) 15 (14.3%) 7 (1.0%)
Postgraduate work 5 (2.9%) 4 (3.8%) 1 (1.4%)
Postgraduate degree 61 (34.9%) 41 (39.0%) 20 (28.6%)
Chronic Conditions
Obesity 132 (73.3%) 74 (68.5%) 58 (80.6%) 3.20 0.074
High Cholesterol 78 (45.1%) 44 (41.9%) 34 (50.0%) 1.09 0.296
High Blood Pressure 81 (44.8%) 42 (38.5%) 39 (54.2%) 4.29 0.038
Anxiety or Other Emotional/Mental Health Condition 47 (26.4%) 30 (27.5%) 17 (23.6%) 0.35 0.557
Diabetes 44 (25.1%) 18 (17.1%) 26 (37.1%) 8.93 0.003
Musculoskeletal Injury/Disorder 41 (22.7%) 23 (21.1%) 18 (25.0%) 0.38 0.540
Depression 40 (22.1%) 21 (19.3%) 19 (26.4%) 1.28 0.258
Arthritis or Other Rheumatic Disease 36 (19.9%) 21 (19.3%) 15 (20.8%) 0.07 0.796
Digestive Diseases/Conditions 35 (19.3%) 20 (18.3%) 15 (20.8%) 0.17 0.679
Asthma 12 (6.6%) 7 (6.4%) 5 (6.9%) 0.02 0.890
Cancer 6 (3.3%) 3 (2.8%) 3 (4.2%) 0.27 0.603
Heart Disease 4 (2.2%) 1 (0.9%) 3 (4.2%) 2.12 0.146
Other Physical Injuries 4 (2.2%) 2 (1.8%) 2 (2.8%) 0.18 0.673
Chronic Bronchitis, Emphysema, or Other COPD 2 (1.1%) 1 (0.9%) 1 (1.4%) 0.09 0.766
Other Lung Diseases 2 (1.1%) 2 (1.8%) 0 (0.0%) 1.34 0.248
Other Chronic Condition 25 (13.9%) 18 (16.5%) 7 (9.9%) 1.59 0.207
Number of Chronic Conditions (range 1 to 16) 3.25 (±2.02) 3.00 (±1.87) 3.64 (±2.19) 2.10 0.037
Body Mass Index (Categorical) 3.94 0.269
Normal Weight (18.5–24.9) 16 (8.9%) 13 (12.0%) 3 (4.2%)
Overweight (25–29.9) 32 (17.8%) 21 (19.4%) 11 (15.3%)
Obese (30–39.9) 89 (49.4%) 50 (46.3%) 39 (54.2%)
Extremely Obese (40+) 43 (23.9%) 24 (22.2%) 19 (26.4%)
Body Mass Index (Continuous) 34.90 (±7.91) 34.20 (±8.30) 35.95 (±7.23) 1.46 0.145
Glucose 103.84 (±36.42) 100.45 (±38.87) 108.89 (±32.03) 1.52 0.131
Elevated (>99 mg/dL) 60 (33.9%) 29 (27.4%) 31 (43.7%) 5.04 0.025
Systolic Blood Pressure 116.24 (±16.37) 114.99 (±14.83) 118.08 (±18.35) 1.40 0.217
Elevated (>119) 42 (23.6%) 24 (22.6%) 18 (25.0%) 0.13 0.716
Diastolic Blood Pressure 76.10 (±9.84) 75.98 (±8.97) 76.26 (±11.06) 0.19 0.851
Elevated (>80) 54 (30.3%) 32 (30.2%) 22 (30.6%) 0.00 0.958
Total Cholesterol 192.20 (±35.30) 190.82 (±34.94) 194.28 (±35.98) 0.64 0.524
Elevated (>199 mg/dL) 74 (41.6%) 43 (40.2%) 31 (43.7%) 0.21 0.645
LDL Cholesterol 109.95 (±30.13) 110.22 (±30.90) 109.54 (±29.13) −0.15 0.884
Elevated (>129 mg/dL) 45 (25.4%) 30 (28.0%) 15 (21.4%) 0.98 0.323
Proportion of Sessions Attended (Categorical) 19.73 <0.001
75–100% Sessions 76 (42.0%) 51 (46.8%) 25 (34.7%)
50–74% Sessions 56 (30.9%) 41 (37.6%) 15 (20.8%)
25–49% Sessions 24 (13.3%) 10 (9.2%) 14 (19.4%)
<25% Sessions 25 (13.8%) 7 (6.4%) 18 (25.0%)
Proportion of Sessions Attended (Continuous) 0.61 (±0.28) 0.68 (±0.24) 0.52 (±0.31) −3.80 <0.001